Phase II drug metabolizing polymorphisms and smoking status...

  • Main
  • 2015 / 12
  • Phase II drug metabolizing polymorphisms and smoking status...
Cancer Prevention Research 2015 / 12

Phase II drug metabolizing polymorphisms and smoking status predict recurrence of non-muscle invasive bladder cancer: a gene-smoking interaction.

Lacombe, L., Fradet, V., Levesque, E., Pouliot, F., Larue, H., Bergeron, A., Hovington, H., Caron, A., Nguile-Makao, M., Harvey, M., Fradet, Y., Guillemette, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Prevention Research
DOI:
10.1158/1940-6207.CAPR-15-0069
Date:
December, 2015
File:
PDF, 612 KB
english, 2015
Conversion to is in progress
Conversion to is failed